Dr Peter Kwong | Chief, Structural Biology Section
NIH | United States

Dr Peter Kwong, Chief, Structural Biology Section, NIH

Dr. Kwong is Chief of the Structural Biology Section at the Vaccine Research Center at the National Institutes of Health.  He is internationally recognized for his work defining structural aspects of the HIV-1 envelope glycoproteins and their interactions with antibodies.  For the last several years, his efforts have focused on applying the atomic-level tools of structural biology to the development of effective vaccines against HIV-1 and other viral pathogens.

Appearances:



DC Pre-congress WS day April 2 @ 09:00

Advances in using structure-based knowledge for smarter vaccine designs

Structure-based vaccines are designed on the rationale that protective epitopes should be sufficient to induce immune responses and provide protection against pathogens, with multiple epitopes inducing a higher immune response. Structure-based vaccines have become a much-anticipated field over the years with increasingly more preclinical and clinical staged developments. This workshop focuses on recent advances and their application in providing protection against infectious diseases.

Progress in Stabilized Pre-fusion Glycoprotein Vaccines for Paramyxoviruses & HIV-1

Using structural based vaccine design to target flavivirus infections: Zika and Dengue

GSK’s CMV structural biology research

Discussion with all speakers
 

back to speakers